Latest Analysis

1,845 tickers · updated regularly
Ranks this page's recent reports by score.
Frontdoor, Inc.
FTDR·Consumer Discretionary
B ★★★Hold
Current$86.47
Target$94.14
Return+8.9%
Aug 17, 2026

Frontdoor is a hyper-efficient, capital-light cash compounder that has successfully engineered record margins and explosive EPS growth through aggressive buybacks, though investors must remain cautious of its stretched valuation premium amid a persistently frozen housing market.

Score
84
Eastern Bankshares, Inc.
EBC·Financials
A ★★★★Buy
Current$23.52
Target$25.25
Return+7.4%
Aug 17, 2026

Eastern Bankshares is an elite, hyper-localized wealth and banking powerhouse trading at a deep discount, leveraging massive insider buying and aggressive buybacks to compound value, though investors must monitor the macro threat of sustained commercial real estate deterioration.

Score
93
H&R Block, Inc.
HRB·Consumer Discretionary
S ★★★★★Strong Buy
Current$54.18
Target$67.54
Return+24.7%
Aug 17, 2026

H&R Block is a ruthlessly efficient, heavily undervalued cash-compounding machine utilizing monopolistic pricing power to aggressively retire its own stock, though investors must monitor the long-term threat of AI automating complex tax advisory.

Score
100
Vishay Intertechnology, Inc.
VSH·Technology
B ★★★Hold
Current$35.08
Target$44.00
Return+25.4%
Aug 17, 2026

Vishay is rapidly transforming into an indispensable, cash-rich infrastructure play for the AI power and electrification supercycles, trading at a heavily discounted valuation, though investors must navigate the margin friction of its massive, highly dilutive factory expansion program.

Score
76
Pegasystems Inc.
PEGA·Technology
B ★★★Hold
Current$32.32
Target$39.36
Return+21.8%
Aug 17, 2026

Pegasystems is generating extraordinary, highly reliable free cash flow while trading at distressed multiples, but investors must remain deeply cautious regarding the acute deceleration in contract growth triggered by paralyzing enterprise confusion over AI deployments.

Score
80
Xenon Pharmaceuticals Inc.
XENE·Healthcare
B ★★★Hold
Current$62.67
Target$82.68
Return+31.9%
Aug 16, 2026

Xenon Pharmaceuticals is poised to monopolize the refractory epilepsy market with a best-in-class, de-risked Kv7 opener backed by an impenetrable $1.25 billion balance sheet, though investors must monitor the FDA submission timeline and emerging Phase 3 competition from Biohaven.

Score
84
Resideo Technologies, Inc.
REZI·Industrials
A ★★★★Buy
Current$20.46
Target$35.00
Return+71.1%
Aug 16, 2026

Resideo is a wildly profitable, pure-play building technology powerhouse trading at a severely distressed multiple due to post-spin leverage panic, though investors must vigilantly monitor management's execution of its aggressive debt-reduction mandate.

Score
90
Zeta Global Holdings Corp.
ZETA·Technology
A ★★★★Buy
Current$29.05
Target$39.93
Return+37.5%
Aug 16, 2026

Zeta is an accelerating, highly profitable AI infrastructure powerhouse trading at a deeply discounted multiple relative to its hyper-growth peers, though investors must remain hyper-vigilant regarding the long-term regulatory headwinds facing proprietary data collection and consent methodologies.

Score
90
Enphase Energy, Inc.
ENPH·Technology
A ★★★★Buy
Current$40.78
Target$59.50
Return+45.9%
Aug 16, 2026

Enphase commands a highly lucrative, quasi-monopolistic US residential solar ecosystem trading at a heavily discounted valuation, though investors must aggressively stomach extreme near-term volatility tied to macroeconomic interest rates and the uncertain, unproven timeline of its AI data center infrastructure rollout.

Score
85
AAR Corp.
AIR·Industrials
A ★★★★Buy
Current$148.16
Target$155.03
Return+4.6%
Aug 16, 2026

AAR is an elite, deeply undervalued logistical tollbooth on the booming aviation aftermarket, structurally guaranteed years of massive growth due to global aircraft manufacturing shortages, though investors must vigilantly monitor the working capital drag caused by its hyper-scaling parts inventory.

Score
88
Ryan Specialty Holdings, Inc.
RYAN·Financials
A ★★★★Buy
Current$41.82
Target$50.34
Return+20.4%
Aug 16, 2026

Ryan Specialty is the indispensable, elite tollbooth of the complex E&S insurance market, currently trading at a highly attractive valuation due to temporary restructuring friction, though investors must remain hyper-vigilant regarding the cyclical softening of commercial property rates and the encroaching capacity of admitted carriers.

Score
86
Granite Construction Incorporated
GVA·Industrials
B ★★★Hold
Current$127.10
Target$158.45
Return+24.7%
Aug 16, 2026

Granite is an elite, vertically integrated infrastructure juggernaut capturing a generational wave of public and data center spending, but aggressive insider selling and a historically stretched valuation suggest the easiest money has already been made.

Score
75
Blue Owl Capital Corporation
OBDC·Financials
A ★★★★Buy
Current$11.72
Target$13.55
Return+15.6%
Aug 16, 2026

Blue Owl Capital Corporation is a premier, highly diversified middle-market lender offering an exceptional double-digit dividend yield secured by strong underwriting, though investors must monitor non-accrual trends and the potential headwind of declining benchmark interest rates on its floating-rate portfolio.

Score
90
ESAB Corporation
ESAB·Industrials
A ★★★★Buy
Current$85.58
Target$108.93
Return+27.3%
Aug 16, 2026

ESAB is executing a masterful, high-margin transformation into an industrial software and inspection powerhouse, trading at a deeply misunderstood discount, though investors must tolerate near-term balance sheet leverage as the company digests its massive acquisition.

Score
86
White Mountains Insurance Group, Ltd.
WTM·Financials
S ★★★★★Strong Buy
Current$2,137.12
Target$2,596.70
Return+21.5%
Aug 16, 2026

White Mountains is a premier, capital-agile financial holding company trading at an unwarranted discount to its rapidly growing book value, though investors must tolerate the quarterly noise generated by mark-to-market equity volatility and reinsurance catastrophe risk.

Score
100
StepStone Group Inc.
STEP·Financials
B ★★★Hold
Current$51.96
Target$66.49
Return+28.0%
Aug 16, 2026

StepStone is quietly building an insurmountable data monopoly within the booming private markets ecosystem, though near-term total returns are capped by a fully priced valuation and a macro environment that continues to delay lucrative performance fee realizations.

Score
76
Legence Corp.
LGN·Industrials
A ★★★★Buy
Current$66.38
Target$105.00
Return+58.2%
Aug 16, 2026

Legence is the premier, pure-play tollbooth for the secular data center and semiconductor reshoring supercycles, offering massive cash generation and a $5.67 billion backlog, though investors must navigate near-term margin mix dilution and heavy insider stock liquidations.

Score
85
Netskope, Inc.
NTSK·Technology
B ★★★Hold
Current$15.81
Target$20.72
Return+31.1%
Aug 16, 2026

Netskope is a highly disruptive, pure-play leader in the exploding SASE market fortified by elite gross retention and undervalued relative to peers, though investors must remain vigilant regarding its persistent free cash flow burn and brutal competition from entrenched platform titans.

Score
78
Navan, Inc.
NAVN·Consumer Discretionary
A ★★★★Buy
Current$29.26
Target$40.69
Return+39.1%
Aug 16, 2026

Navan is fundamentally rewiring the $185 billion corporate travel and expense ecosystem via high-margin, AI-orchestrated automation, delivering explosive 40% growth and inflecting profitability, though investors must tolerate premium valuation multiples tethered to the cyclical nature of global business travel.

Score
85
Ascendis Pharma A/S
ASND·Healthcare
A ★★★★Buy
Current$255.46
Target$310.00
Return+21.4%
Aug 16, 2026

Ascendis Pharma's TransCon technology platform is rapidly scaling a highly profitable rare disease portfolio led by Yorvipath and Yuviwel, though investors must monitor ongoing BioMarin patent litigation and reliance on a single drug delivery mechanism.

Score
86
Reynolds Consumer Products Inc.
REYN·Consumer Discretionary
B ★★★Hold
Current$26.25
Target$28.80
Return+9.7%
Aug 16, 2026

Reynolds is an incredibly durable, cash-printing consumer staples monopoly trading at a noticeable discount to peers, though investors must pragmatically accept stagnant top-line growth and structural headwinds in its legacy foam tableware divisions.

Score
82
Blackstone Secured Lending Fund
BXSL·Financials
B ★★★Hold
Current$25.01
Target$26.04
Return+4.1%
Aug 16, 2026

Blackstone Secured Lending is a best-in-class, ultra-defensive credit fortress offering a massive 12.3% yield anchored by a 97% first-lien portfolio, though investors must remain hyper-vigilant regarding near-term dividend sustainability as falling base rates relentlessly compress net investment income.

Score
78
Phillips Edison & Company, Inc.
PECO·Real Estate
B ★★★Hold
Current$40.43
Target$45.54
Return+12.6%
Aug 16, 2026

Phillips Edison wields supreme pricing power over an unshakeable, grocery-anchored retail empire that generates pristine, growing cash flows, though the stock's near-term upside is heavily capped by relentless ATM equity dilution used to fund its aggressive acquisition pipeline.

Score
84
Brookfield Wealth Solutions Ltd.
BNT·Financials
B ★★★Hold
Current$45.03
Target$49.97
Return+11.0%
Aug 16, 2026

Brookfield Wealth Solutions is a rapidly scaling, highly profitable capital engine for the world's premier alternative asset manager, offering a massive discount to intrinsic value that will be mechanically unlocked by its impending corporate merger, though investors must tolerate extreme short-term statutory earnings volatility.

Score
77